Schistosomiasis

Digestion

Volumn 59, Issue 5, 1998, Pages 589-605

  El Garem, Ahmed Ali ^a,b  

^a CAIRO UNIVERSITY   (Egypt)

^b NONE   (Egypt)

Author keywords

Bilharsiasis; Immunopathology; Pathogenesis; Schistosomiasis; Treatment

Indexed keywords

METRIFONATE; OXAMNIQUINE; PRAZIQUANTEL;

AFRICA; ASIA; BLADDER; BRAIN; CELLULAR IMMUNITY; CLINICAL FEATURE; COLON; DELAYED HYPERSENSITIVITY; DEVELOPING COUNTRY; HUMAN; INFECTION CONTROL; INTERMEDIATE HOST; LIFE CYCLE; LIVER; MOLLUSC; PATHOGENESIS; PORTAL VEIN BLOOD; PRIORITY JOURNAL; REVIEW; SCHISTOSOMIASIS; SKIN; SOUTH AMERICA; TREMATODE; URETER; VACCINATION; WATER CONTAMINATION;

ANIMALS; ANTIBODIES, HELMINTH; HUMANS; PROTOZOAN VACCINES; SCHISTOSOMA; SCHISTOSOMIASIS; SCHISTOSOMICIDES; VACCINATION;

EID: 0031878785     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007534     Document Type: Review

References (126)

1. Ruffer MA: Note on the presence of Bilharzia haematobium in Egyptian mummies of the 20th dynasty 1220-1000 BC. Br Med J 1910; 2557:16.
2. Strickland GT, Abdel-Wahab MF: Hunter's Tropical Medicine, ed 7. Chapter on Schistosomiasis. Philadelphia, Saunders, 1991, pp 781-809.
3. Davis A: Schistosomiasis; in Cook G (ed): Manson's Tropical Diseases. London, EL-BS/ Saunders, 1996, pp 1413-1456.
4. Dessein AJ, Abel L, Carvallo EM, Prata A: Environmental, genetic and immunological factors in human resistance to Schistosoma mansoni. Immunological investigations 1992; 21:423-453.
5. Butterworth AE, Dunne DW, Fulford AIC, Ouma JH, Sturrock RE: Immunity and morbidity in Schistosoma mansoni infection: Quantitative aspects. Am J Trop Med Hyg 1996;55:109-115.
6. Jassim A, Hassan K, Catty D: Antibody isotypes in human schistosomiasis mansoni. Parasit Immunology 1987;9:627-650.
7. Dunne DW, Grabowska AM, Fulford AJC, Butterworth AE, Sturrock RF, Koech D, Ouma JH: Human antibody responses to Schistosoma mansoni: The influence of epitopes shared between different life-cycle stages on the response to the schistosomula. Eur J Immunol 1988;18: 123-131.
8. Rozshyay Z, Sarmay G, Walker M, Maslauka K, Valasek Z, Jefferis R, Gergely J: Distinctive role of IgG1 and IgG3 isotypes in Fc8R-mediated functions. Immunology 1989;66:498.
9. Dunne DW, Richardson BA, Jones FM, Clark M, Thorne KJ, Butterworth AE: The use of mouse/human chimaeric antibodies to investigate the roles of different antibody isotypes including IgA2 in the killing of Schistosoma mansoni schistosomula by eosinophils. Parasit Immunology 1993;15:181-185.
10. Demeare CE, Rihet P, Abel L, Ovattara M, Bourgois A, Dessein AJ: Resistance to Schistosoma mansoni in humans. Influence of IgE/ IgG4 balance and IgG, in immunity to reinfection after chemotherapy. J Infect Dis 1993;168: 1000-1008.
11. Rihet P, Demeure CE, Dessein AJ, Bourgois A: Strong serum inhibition of specific IgE correlated to competing IgG4 revealed by a new methodology in subjects from a Schistosoma mansoni area. Eur J Immunol 1992;22:2063-2070.
12. Butterworth AE, Bensted-Smith R, Capron A, Duiton PR, Dunne DW, Grzych JM, Kariaki HC, Khalife J, Koech D, Muyambi M, Ouma JH, Singok JK, Sturrock RF: Schistosomiasis mansoni: Preventing by blocking antibodies of the expression of immunity in young children. Parasitology 1987;94:281-300.
13. Abdel Wahab MF, Strickland GT: Abdominal ultrasonography for assessing morbidity from schistosomiasis. 2. Hospital studies. Trans R Soc Trop Med Hyg 1993;87:135-137.
14. Pitchford RJ, Visser PS: The role of naturally infected wild rodents in the epidemiology of schistosomiasis in the Eastern Transvaal. Trans R Soc Trop Med Hyg 1962;56:126-135.
15. Simpson AJG, Smithers SR: Schistosomes surface, egg and circulating antigens. Curr Top Microbiol Immunol 1985;120:205-239.
16. Mott KE, Dixon II: Collaborative study on antigens for immunodiagnosis of schistosomiasis. Bull Wld Hlth Org 1982;60:729-753.
17. Barsoum RS, Bassily S, Solimam MM, Ramzy MF, Milad AM, Hassaballa A: Renal amyloidosis and schistosomiasis. Trans R Soc Trop Med Hyg 1979;73:367-374.
18. Warren KS: The immunopathology of schistosomiasis: A multidisciplinary approach. Trans R Soc Trop Med Hyg 1972;66:417-434.
19. Weinslock JV: The pathogenesis of granulomatous inflammation and organ injury in schisto-somiasis: Interactions between the schistosoma ova and the host. Immunol Invest 1992;21: 455-475.
20. Chensue SW, Warmington DS, Hershey SD, Terebuh PD, Othman M, Kunkel L: Evolving T cell responses in murine schistosomiasis: Th2 cells mediate secondary granulomatous hyper-sensitivity and are regulated by CD8+ T cells in vivo. J Immunol 1993;151:1391-1400.
21. Bevillaqua MP: Endothelial leucocyte adhesion molecules. Annu Rev Immunol 1993;11:767-804.
22. Ritter DM, Mckerrow JH: Intercellular adhesion molecule I is the major adhesion molecule expressed during schistosome granuloma formation. Infect Immun 1996;64:4706-4713.
23. Dustin ML, Rothlein R, Bhan AK, Dimarello CA, Springer TA: Induction by IL-I and interferon-γ, tissue distribution, biochemistry and function of a natural adhesion molecule (ICAM-1). J Immunol 1986;137:245-254.
24. Lukacs NW, Chensue SW, Strieter RM, Warmington K, Kunkel SL: Inflammatory granuloma formation is mediated by TNF-α inducible intercellular adhesion molecule-1. J Immunol 1994;152:5883-5889.
25. Secor WE, Dos Reis MG, Ramos EAG, Matos EP, Reis EAG, Do Carmo TMA, Harn DA: Soluble intercellular adhesion molecules in human schistosomiasis: correlation with disease severity and decreased responsiveness to egg antigens. Infect Immunol 1994;621:2695.
26. Linsley PS, Clark EA, Ledbetter JA: Cell antigen, CD28, mediates adhesion with B cells by interacting with the activation antigen B7/ BB-1. Proc Natl Acad Sci USA 1990;87:5031-5035.
27. Weinstock JV, Blum AM: Modulation of granulomatous inflammation in murine Schisiosomiasis mansoni by enteric exposure to schistosome ova: In vitro characterization of a regulatory mechanism within the grauuloma. Cell Immunol 1987;108:452-459.
28. Yamashita T, Boros DL: IL-4 influences IL-2 production and granulomatous inflammation in murine Schistosomiasis mansoni. J Immunol 1992;149:3659.
29. Mosmann TR, Coffman RL: Th1, and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-173.
30. Firestein GS, Roeder WD, Laxer JA, Towns-end KS, Weaver CT, Horn JT, Linton JH, Torbett BE, Glasebrook AL: A new murine, CD4+ T cell subset with an unrestricted cytokine profile. Immunology 1989;143:518-525.
31. Cofman RL, Seymour BWP, Hudak S, Jackson J, Remmick D: Antibody to interlukin 5 inhibits helminth-induced eosinophilia in mice. Science 1989;245:308-310.
32. Sher A, Coffman RL, Heiny S, Scott P, Cheever AW: Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. Proc Natl Acad Sci USA 1990;87:61-65.
33. Andrade ZA, Warren KS: Mild prolonged schistosomiasis in mice: Alterations in host response with time and the development of portal fibrosis. Trans R Soc Trop Med Hyg 1964; 58:53-57.
34. Warren KS, Domingo EO: Granuloma formation and Schistosoma mansoni, Schistosoma haemalobium and 5. japonicum egg. Size and rate of development cellular composition, cross sensitivity and rate of egg destruction. Am J Trop Med Hyg 1970;19:292-304.
35. Von Lichtenberg EC, Sadun EH: Experimental production of bilharzial pipe-stem fibrosis in chimpanzee. Exp Parasitol 1968;22:264-278.
36. Stadecker MJ: The role of T-cell anergy in the immunomodulation of schistosomiasis. Parasitol Today 1992;8:199-204.
37. Flores Villaneuva PO, Chikanguno SM, Harris TS, Stadecker MJ: IL-10 inhibits macrophage co-stimulatory activity by selectively inhibiting the up-regulation of B7 expression. Immunology 1993;151:1224-1243.
38. De Waal Malefty R, Abrams J, Bennit B, Frigdor CG, De Varies JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-1220.
39. Ding L, Linsley PS, Huang LY, Germaine RN, Shevach EM: IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 1993;151:1224-1234.
40. Czaja MJ, Giambran MA, Zern MA: Transforming growth factor-B stimulates collagen synthesis in vitro and is elevated in a vivo model of hepatic fibrosis. Hepatology 1987;7:1028-1045.
41. Wynn TA, Eltoum I, Oswald IP, Cheever AW, Sher A: Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. Exp Med 1994:179: 1551-1561.
42. Doughty BL, Phillips SM: Delayed hypersensitivity granuloma formation around Schistosoma mansoni eggs in vitro. II. Regulatory T cell subsets. J Immunol 1982;133:933-940.
43. Perrin PJ, Phillips SM: The molecular basis of granuloma formation in schistosomiasis. III. In vivo effects of T-cell derived suppresor-effects our factor and IL-2 on granuloma formation. J Immunol 1989;143:649-655.
44. Doughty BL, Goes AM, Parra JC, Rocha R, Cone JC, Colley DG, Gazzinelli G: Anti-idiotypic T cells in human schistosomiasis. Immunol Invest 1989;18:373-388.
45. Bonney RJ, Wightman PD, Naruns P, Richardson TG, Davies P, Humes JL: Immune complexes cause the synthesis and release of prostaglandins and the release of lysosomal and hydrolase from macrophages. Fed Proc 1978; 37:1353-1358.
46. Wyler DJ: Why does liver fibrosis occur in schistosomiasis? Parasitol Today 1992;8:277-279.
47. El-Badrawy NM, Hassanein HI, Botros SS, Nagy FM, Abdallah NM, Herbage D: Effect of Praziquantel on hepatic fibrosis in experimental Schistosomiasis mansoni. Exp Mol Pathol 1988;49:151-160.
48. Grimaud JA, Boros C, Takiya R, Mathew C, Emenod H: Collagen isotype, laminin and fibronectinin granuloma of the liver and intestine of Schistosoma mansoni infected mice. Am J Trop Med Hyg 1987;37:335-344.
49. Grimaud JA, Borojevic R: Chronic human Schistosomiasis mansoni, pathology of the Disse space. Lab Invest 1977;36:268-273.
50. Grimaud JA, Druguet M, Peyrol S, Chevalier O, Herbage D, El-Badrawy N: Collagen immunotyping in human liver: Light and electron microscope study. Histochem Cytochem 1980; 28:1145-1156.
51. Hassanein H, Herbage D, Chevalier O, Buffevant C, Grimaud JA: Solubilization and characterisation of human liver collagen in Schistosomiasis mansoni. Cell Mol Biol 1983;29:139-148.
52. Wick G, Brunner H, Penner E, Timpl R: The diagnostic application of specific anticollagen sera. II. Analysis of liver biopsy. Int Archs Allergy Appl Immunol 1978;26:316-322.
53. Rohde H, Vargas LL, Hahn E, Kalbfleisch H, Bruguera M, Timpl R: Radio-immunoassay for type III procollagen peptide and its applications to human liver disease. Eur J Clin Invest 1979;9:451-459.
54. Fayol V, Hassanein HJ, ElBadrawy N, Ville G, Hartmann DJ: Aminoterminal propeptide of type III procollagen: A marker of disease activity in schistosomal patients. Eur J Clin Chem Clin Biochem 1991;29:737-741.
55. Farid Z, Bassily S, Kent DC, Sanborn WR, Hassan A, Abdel Wahab MF: Chronic urinary salmonella carriers with intermittent bacteraemia. Am J Trop Med Hyg 1970;73:153-156.
56. Brand KG: Schistosomiasis-cancer. Etiological consideration. Acta Trop 1979;36:203-214.
57. Cheever AW, Kamel IA, Elwi AM, Mosimann JE, Danner R, Sippel JE: Schistosoma mansoni and Schistosoma haematobium infection in Egypt. III. Extrahepatic pathology. Am J Trop Med Hyg 1978;27:55-75.
58. Mousa AH, ElGarem AA: Hypertrophie osteoarthropathy in visceral bilharziasis. J Egypt Med Assoc 1956;39:717-729.
59. Symmcrs WSC: Note on a new form of liver cirrhosis due to the presence of the ova of Bilharzia haematobium. Pathol Bact 1904;9:237-239.
60. Elwi AM: Pathology of schistosomiasis; in Compiled review on Bilharziasis. Cairo, National Documentation Center (NIDC) Egyptian Academy of Science and Technology, 1976.
61. Mousa AH, Atta AA, El Rooby A, ElGarem AA, AbdelWahab MF, El Raziky S, Hamed A: Clincopathological aspects of hepatosplenic bilharziasis: in Mostofi FR (ed): Bilharziasis, International Academy of Pathology. Special Monograph. Heidelberg, Springer, 1967, pp 15-29.
62. Bassily S, Farid Z, Higashi GI, Kamel IA, ElMasri NA, Watten RH: Chronic hepatitis B antigenaemia in patients with hepatosplenic schistosomiasis. J Trop Med Hyg 1979;82:248-251.
63. Zakaria S, Mabrouk MA, ELsherif N, Zakaria E, Said El-Din SM, Kamel MA, Elgarem A: T helper and T suppressor cells in schistosomal and non-schistosomal chronic liver disease. Egypt J Bilh 1993;15:17-27.
64. Omran SA: Haematology of schistosomiasis. Update review article. Egypt J Bilh 1992;14: 1-7.
65. Omran SA, Bassiouni FL, Amer AM, Hussein AT: Fibrinolytic parameters during acute haematemesis in endemic hepatosplenomegaly. Blood Coagul Fibrinolysis 1993;4:891-894.
66. Omran SA, Amin HM, ELBassiouni NE, Essawy FM, Toiema SM: Vitamin K dependent coagulation proteins in endemic hepatosplenomegaly in Egypt. J Clin Pathol 1994;47: 502-504.
67. Omran SA, ELBassiouni NE, Hussein NA, Aide MM, Hussein AT, Mohamed AA: Disseminated intravascular coagulation in endemic hepatosplenic schistosomiasis. Homeostasis 1995;25:218-228.
68. Hassan M: Study of prostaglandins in hepatosplenic schistosomiasis; thesis, Clinical and Chemical Pathology. Faculty of Medicine, Cairo University, 1988.
69. El Roubi O, Kamel L, Hassan M, Abdel Hamid F, abdel Rahman H: Effect of sex hormones and amino-acid changes in chronic liver disease. 13th Egyptian Chem Conf, 1993, pp 287-298.
70. Abdel Rahman H, ElShanawany F, Salem M, ElSahly A: Alkaline phosphatase, isoenzymes in hepatic schistosomiasis. Egypt J Bilh 1993; 15:41-48.
71. AbuZikri N: Role of catecholamines, renin and aldosterone in oesophageal variceal bleeding of schistosomal hepatic fibrosis; thesis, Clinical and Chemical Pathology. Faculty of Medicine, Cairo University, 1991.
72. Allam M: Somatostatin in hepatosplenic schistosomiasis: Role in variceal bleeding: thesis, Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, 1992.
73. Mousa AH, ElGarem A: The haemodynamic study of Egyptian hepatosplenic bilharziasis. J Egypt Med Assoc 1959;42:444-455.
74. Mousa AH, Atta AA, ElRooby A, ElGarem A, Abdel Wahab MF, El Raziky S, Hamed A: Portal hypertension in hepatosplenic Bilharziasis. J Trop Med Hyg 1965;68:196-199.
75. Mousa AH, Atta AA, ElRooby A, ElGarem AA, Saif M, Zein Elabdin A: Hepatic blood flow in hepatosplenic Bilharziasis. J Trop Med Hyg 1966;69:45-50.
76. Abdel Wahab MF, Salama ZA, El kady NM, Arafa NA: The use of ultrasonography in diagnosis of different schistosomal syndromes; in El Halafawy et al (eds): Proc 3rd Int Workshop on Diagnostic Ultrasound Imaging. NSF Cairo University Technology Transfer Focus and Alliance for Engineering in Medicine and Biology, 1978, pp 457-466.
77. Abdel Wahab MF, Esmat GM, Farrg AI, ElBorraey YA, Strickland GT: Grading of hepatic schistosomiasis by the use of ultrasonography. Am J Trop Med Hyg 1992;46:403-408.
78. Doehring-Schwerdtfeger E, Ali GM, Abdel Rehim IM, Kardorff R, Franke D, Kaiser C, ElSheikh M, Ehrich JH: Sonographic abnormalities in Sudanese children with Schistosoma mansoni infection: A proposed staging system for field diagnosis of periportal fibrosis. Am J Trop Med Hyg 1989;41:63-69.
79. Abdel Wahab MF, Esmat G, Farrag A, ElBoraey Y, Strickland GT: Ultrasonographic prediction of oesophageal varices in Schistosomiasis mansoni. Am J Gastroenterol 1993;88:560-563.
80. Salama ZA, Kasem AM, Labib SS, Ramzy II, Yousef MM, Abdel Reheem AY, ElTalkhawy MD, Hunter MS: Endosonographic studies in cases of portal hypertension due to chronic liver disease. J Egypt Med Assoc 1995;78:345-353.
81. Salama ZA, El Dorry AK, Soliman MT, Esmail EF: Doppler sonography of the portal circulation in cases with portal hypertension. Med J Cairo Univ 1997;65:347-359.
82. Feldmeier H: Diagnosis of Schistosomiasis. Human schistosomiasis; in Jordan P, Webbe G, Sturrock RF (eds). Wallingford, Oxon., CAB International, 1993, pp 271-303.
83. Ruppel A, Idris MA, Suleiman SM, Hilali AMH: Schisiosoma mansoni diagnostic antigens (SM31/12): A seroepidemiological study in the Sudan. Trop Med Parasitol 1990;41: 127-130.
84. Rossi CL, Tsang VCM, Pilcher JB: Rapid, low-technology field - and laboratory - applicable enzyme-linked immunosorbent assays for immunodiagnosis ofSchistosoma mansoni. J Clin Microbiol 1991;29:1836-1841.
85. Hancock K, Mohamed YB, Haichou X, Noh J, Dotson EM, Tsang VCW: A recombinant protein from Schistosoma mansoni useful for the detection of S. mansoni and Schistosoma haematobium antibodies. J Parasitol 1997;83: 612-618.
86. King CH, El Ibiary S, El Nawawi M, Sawyer J, Griffin A, Elhawey A, Mahmoud AAF: Intensity of Schistosoma mansoni infections in a human population is inversely correlated with antibody response to Sm W 68, a protective parasite antigen. J Infect Dis 1989;160:686-691.
87. Correa-Oliveira R, Pearce EJ, Oliveira GC, Golgher DB, Katz N, Bahia LG, Carvalho OS, Gazzinelli G, Sher A: The human immune response to defined immunogens of Schistosoma mansoni: Elevated antibody levels to paramyosin in stool-negative individuals from two endemic areas in Brazil. Trans R Soc Trop Med Hyg 1989;83:798-804.
88. Auriault C, Gras-Masse H, Pierce RJ, Butterworth AE, Wolowezuk I, Capron M, Ouma JH, Balloul JM, Khalife J, Neyrinck JL: Antibody response of Schistosoma mansoni-infected human subjects to the recombinant P 28 glutathione-S-transferase and its synthetic peptides. J Clin Microbiol 1990;9:1918-1924.
89. Nash TE, Prescott B, Neva FA: The characteristics of a circulating antigen in Schistosomiasis. J Immunol 1974;112:1500-1507.
90. Nash TE, Deelder AM: Comparison of four schistosome excretory-secretory antigens: Phenol sulfuric test active peak, cathodic circulating antigen, gut associated proteoglycan and circulating anodic antigen. Am J Trop Med Hyg 1985;34:236-241.
91. Gunderseu SG, Haagensen I, Jonassen TO, Figenschau KJ, de Jonge N, Decider AM: Magnetic beed antigen capture enzyne-linked immunoassay in microtitre trays for rapid detection of schistosomal circulating anodic antigen. J Immunol Methods 1992;148:1-8.
92. Deeder AM, De Jonge N, Fillie YE, Kornelis D, Helaba D, Qian ZL, De Calume P, Polderman AM: Quantitative determination of circulating antigens in human Schistosomiasis mansoni using an indirect haemagglutination assay. Am J Trop Med Hyg 1989;40:50-54.
93. Feldmeier H, Nogueira-Queiroz JA, Peixoto-Queiroz MA, Doehring E, Dessaint JP, Alencar JE, Daffalla AA, Capron A: Detection and quantification of circulating antigen in schistosomiasis by monoclonal antibody. II. The quantification of circulating antigens in human Schistosomiasis mansoni and haematobium: Relationship to intensity of infection and disease status. Clin Exp Immunol 1986;65P:232-243.
94. Gundersen SG, Haagensen I, Jonassen TO, Figenschau KJ, de Jonge N, Deelder AM: Quantitative detection of schistosomal circulating anodic antigen by a magnetic bead antigen capture enzyme-linked immuno-sorbent assay (MBAC-EIA) before and after mass chemotherapy. Trans R Soc Trop Med Hyg 1992;86:175-178.
95. Hassan MM, Badawi MA, Strand M: Circulating Schistosomal antigen in diagnosis and assessment of cure in individuals infected with Schistosoma mansoni. Am J Trop Med Hyg 1992;46:737-744.
96. Nourel Din MS, Kornelis D, Van Zeyl RJM, Deelder AM: Immunologic characterisation of two monoclonal antibodies reactive with repetitive carbohydrate epitopes of circulating Schistosoma mansoni egg antigen. Am J Trop Med Hyg 1994;50:487-498.
97. Nourel Din MS, Nibbeling R, Rotmans JP, Polderman AM, Krijger FW, Deelder AM: Quantitative determination of circulating soluble egg antigen in urine and serum of Schistosoma mansoni-infected individuals using a combined two-site enzyme-linked immunosorbent assay. Am J Trop Med Hyg 1994;50:585-594.
98. Mohamed SH, Demerdash ZA, Shaker ZA, Mansour MM, Saadel Din HA, Abadeer NJ: Production and characterization of a monoclonal antibody reactive with a repetitive epitope of concanavalin A-bound glycoprotein fraction of Schistosoma mansoni soluble egg antigen. J Egypt Med Assoc 1995;78:37-49.
99. Demerdash ZA, Mohamed SH, Shaker ZA, Hassan SI, El Attar GM, Saadel Din HA, Abadeer NI, Mansour MM: Detection of circulating schistosome antigens in serum and urine of schistosomiasis patients and assessment of cure by a monoclonal antibody. Egypt Soc Parasitol 1995;25:471-484.
100. Shaker ZA: Pers. commun.
101. Davis A: Antischistosomal drugs and clinical practice. Human schistosomiasis. Jordan P, Webbe G, Sturrock RF (eds): Wallingford, Oxon., CAB International, 1993.
102. Ismail M, Metwally A, Farghaly A, Bruce J, Tao L, Bennett JL: Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. Am J Trop Med Hyg 1996;55:214-218.
103. Hagan P, Blumenthal VJ, Dunn D, Simpson AIG, Wilkens HA: Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 1991;349:243-245.
104. Rihet P, Demeure CE, Bourgois A, Dessein AJ: Evidence for an association between human resistance to Schistosoma mansoni and high antilarval IgE levels. Eur J Immunol 1991;21:2679-2686.
105. Fenwick A: The role of mollusciciding in schistosomiasis control: Experience in mollusciciding to control schistosomiasis. Parasitol Today 1987;3:70-73.
106. Dean DA, Murrell KD, Shoutai X, Mangold BL: Immunization of mice with ultraviolet-irradiated Schistosoma mansoni cercariae: a re-evaluation. Am J Trop Med Hyg 1983;32: 790-793.
107. Caulada-Benedetti Z, AlZamel F, Sher A, James S: Comparison of Th1- and Th2-associated immune reactivities stimulated by single versus multiple vaccination of mice with irradiated Schistosoma mansoni cercariae. J Immunol 1991;146:1655-1660.
108. Mangold BL, Dean DA: Passive transfer with serum and IgG antibodies of irradiated cercariae-induced resistance against Schistosoma mansoni in mice. J Immunol 1986;136: 2644-2648.
109. Soisson LMA, Masterson CP, Tom TD, McNally MT, Lowell GH, Strand M: Induction of protective immunity in mice using a 62-kDa recombinant fragment of a Schistosoma mansoni surface antigen. J Immunol 1992;149:3612-3620.
110. Bergquist NR: Controlling schistosomiasis by vaccination: A realistic option? Parasitol Today 1995;11:191-194.
111. Oligino LD, Percy AJ, Harn DA: Purification and immunochemical characterization of a 22 kilodalton surface antigen from Schistosoma mansoni. Mol Biochem Parasitol 1988; 28:95-101.
112. Harn DA, Mitsuyama M, Huguenel ED, David JR: Schistosoma mansoni: Detection by monoclonal antibody of a 22,000-Dalton surface membrane antigen which may be blocked by host molecules on lung stage parasites. J Immunol 1985;135:2115-2120.
113. Reynolds SR, Shoemaker CB, Harn DA: T and B cell epitope mapping of Sm23, an integral membrane protein of Schistosoma mansoni. J Immunol 1992;149:3995-4001.
114. Shoemaker C, Gross A, Gebremicheal A, Harn D: DNA cloning and functional expression of the Schistosoma mansoni protective antigen triose-phosphate isomerase. Proc Natl Acad Sci USA 1992;89:1842-1846.
115. Balloul JM, Sondermyer P, Dreyer D, Capron M, Grzych JM, Pierce RJ, Carvallo D, Lecoq P, Capron A: Molecular cloning of a protective antigen of schistosomes. Nature 1987; 326:149-153.
116. Boulanger D, Reid GDF, Sturrock RF, Wolowczuk I, Balloul JM, Grezel D, Pierce RJ, Otieno MF, Guerret S, Grimaud JA, Butterworth AE, Capron A: Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoni. Parasite Immunol 1991;13:473-490.
117. Lanar DE, Pearce EJ, James SL, Sher A: Identification of paramyosin as Schistosome antigen recognized by intradermally vaccinated mice. Science 1986;234:593-596.
118. Butterworth AE, Hagan P: Immunity in human schistosomiasis. Parasitol Today 1987;3: 11-16.
119. Dessein AJ, Begley M, Demeure C, Caillol D, Fueri J, Dos Reis MG, Andrade ZA, Prata A, Bina JC: Human resistance to Schistosoma mansoni is associated with IgG reactivity to a 37-kDa larval surface antigen. J Immunol 1988;140:2727-2736.
120. Goudot-Crozel V, Caillol D, Djabali M, Dessein AJ: The major parasite surface antigen associated with human resistance to schistosomiasis is a 37-kD glyceraldehyde-3P-dehydrogenase. J Exp Med 1989;170:2065-2080.
121. El Ridi R, Farouk F, Sherif M, AlSherbiny M, Osman A, El Gengehi N, Shoemaker CB: T and B cell reactivity to a 42-kDa protein is associated with human resistance to both Schistosomiasis mansoni and haematobium. Submitted, 1997.
122. Shoemaker C, Elridi R: Pers. commun., 1997.
123. Elridi R, Shoemaker CB: Pers. commun., 1997.
124. Webster M, Fulford AJC, Braun G, Duma JH, Kariuki HC, Havercroft JC, Gachuhi K, Sturrock RF, Butterworth AE, Dunne DW: Human immunoglobulin E responses to arecombinant 22,6-kilodalton antigen from Schistosome mansoni adult worms are associated with low intensities of reinfection after treatment. Infect Immunity 1996;64:4042-4046.
125. Moser D, Tendler M, Griffiths G, Klunkert MQ: A 14-kDa Schistosoma mansoni polypeptide is homologous to a gene family of fatty acid binding proteins. Biol Chem 1991; 266:8447-8454.
126. Hassanein H, Aki M, Shaker Z, ElBaz H, Charmy R, Rabei I, Botros S: Induction of hepatic egg granulome hyporesponsiveness in murine schistosomiasis mansoni by intravenous injection of small doses of soluble egg antigen. APMIS 1997, in press.